Vaccine composition comprising 5'-cap modified RNA

Details for Australian Patent Application No. 2010281042 (hide)

Owner Johannes Gutenberg-Universitat Mainz Uniwersytet Warszawski BioNTech AG

Inventors Sahin, Ugur; Kuhn, Andreas; Darzynkiewicz, Edward; Jemielity, Jacek; Kowalska, Joanna

Agent Dibbens Intellectual Property

Pub. Number AU-A-2010281042

PCT Pub. Number WO2011/015347

Priority 09010124.7 05.08.09 EP

Filing date 3 August 2010

Wipo publication date 10 February 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/015347 Priority application(s): WO2011/015347

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010281043-Responsiveness to angiogenesis inhibitors

2010281034-Method and device for cooling a fine grained solid bulk while exchanging the open space gas contained therein simultaneously